CD56 and CD11b Positivity with Low Smac/DIABLO Expression as Predictors of Chemoresistance in Acute Myeloid Leukaemia: Flow Cytometric Analysis

Document Type : Research Articles

Authors

1 Department of Medical Oncology and Haematological Malignancies, South Egypt Cancer Institute, Assiut University, Egypt.

2 Department of Clinical Pathology, South Egypt Cancer Institute, Assiut University, Egypt.

3 Department of Clinical Pathology, Faculty of Medicine, South Valley University, Qena, Egypt.

4 Department of Medical Biochemistry-Faculty of Medicine- South Valley University, Qena, Egypt.

Abstract

Background: Resistance to chemotherapy is a major obstacle to curing acute myeloid leukaemia (AML), and
several antigens are claimed to play primary roles in this resistance. Purpose: The aim of this study was to evaluate
the roles of CD56, CD11b and Smac/DIABLO gene expression levels as prognostic markers of the clinical outcome,
response to chemotherapy and survival of AML patients. Materials and Methods: A cross-sectional observational
study was conducted on 60 naïve-AML patients who received induction therapy with mitoxantrone and cytarabine
combined with a high dose of cytarabine. The CD56,CD11b and Smac/DIABLO expression levels were assessed using
flow cytometry at diagnosis and were analysed for correlation with the possible associated risk factors, response to
chemotherapy, and median duration of disease-free survival (DFS) and overall survival (OS). Results: The overall results
revealed that AML patients who exhibited positive expression for CD56 and CD11b had short median durations of DFS
and OS.(P = 0.019, 0.006, 0.029 and 0.024, respectively). Additionally, low Smac/DIABLO expression had a negative
impact on treatment outcome in terms of CR rate (p=0.012) and reduced DFS (p=0.000) and OS(p=0.000) values.
Conclusions: CD56 and CD11b positivity and low Smac/DIABLO expression are important predictive factors for
the occurrence of chemoresistance, in addition to other risk factors, among AML patients.

Highlights

 

Keywords

Main Subjects


Volume 19, Issue 11
November 2018
Pages 3187-3192
  • Receive Date: 26 April 2018
  • Revise Date: 06 September 2018
  • Accept Date: 08 October 2018
  • First Publish Date: 01 November 2018